OGM VIA customers represent a meaningful software revenue stream and a natural on-ramp to broader Bionano Genomics, Inc.
Good day, and welcome to the Bionano Fourth Quarter and Full Year 2025 Earnings Conference Call. Today's conference is being recorded. At this time, I would like to turn the conference over to Webb ...
The whole-exome sequencing (WES) significantly improves diagnostic accuracy for monogenic foetal structural anomalies (FSAs), ...
Bionano Genomics, Inc. (NASDAQ:BNGO) Q4 2025 Earnings Call Transcript March 23, 2026 Bionano Genomics, Inc. reports earnings ...
Infectious keratitis remains a leading cause of corneal blindness and visual impairment worldwide, with bacterial, fungal, ...
Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look ...
Methods developed and validated to establish the “World Bank of NK Cells” from healthy donors and cancer patientsSingle ...
Wrapping up Q4 earnings, we look at the numbers and key takeaways for the life sciences tools & services stocks, including 10x Genomics (NASDAQ:TXG) and its peers.
Morning Overview on MSN
20-year mouse cloning study finds genetic flaws build up over time
Two decades of cloning experiments in mice have produced a striking pattern: animals created through somatic cell nuclear ...
Background Chromosome 19 is the most gene-dense chromosome in the human genome, with a high frequency of segmental ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results